ACTRN12611001180909尚未招募不适用
Is the titer of Anti HBS Ab in cirrhotic patients receiving double dose HBV vaccine and simultaneous granulocyte-colony stimulating factor (G-CSF) higher compared to cirrhotic patients receiving only double dose HBV vaccine?
Kamran Bagheri Lankarani0 个研究点目标入组 40 人开始时间: 2011年11月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
入排标准
- 年龄范围
- 20 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Cirrhotic patients between 20 and 65 years on waiting list for liver transplantation
排除标准
- •1. Previous history of viral hepatitis (HBS POSITIVE OR anti HBC Ab positive 2. HIV patients 3. Those patients who has history of vaccination 4. Patients with hepatocellular carcinoma 5. Patients with congestive heart failure (class III and IV) 6. Patients with serum creatinine >1.5 mg/dL 7. Patients with hypersensitivity to GM-CSF
- •8. Using immunosuppresive agents like azathioporine, tacrolimus.....
研究者
相似试验
尚未招募
1 期
The Effect of Granulocyte Colony Stimulating Factor (GCSF) on Immune Response to Hepatitis B Vaccine in End-Stage Renal Disease (ESRD) Patients Undergoing HemodialysisImmunity against hepatitis B virusRenal and Urogenital - Other renal and urogenital disordersInfection - Other infectious diseasesACTRN12611000246987Kamran Bagheri Lankarani100
招募中
2 期
HBsAg seroclearance in non-cirrhotic, HBeAg-negative chronic hepatitis B patients who discontinue tenofovir or entecavirHBsAg seroclearanceHBsAg seroclearance,HBeAg CHB onfection,Tenofovir,Entercavir,DicontinuationTCTR20190609001Faculty of Medicine Siriraj Hospital420
Unknown
不适用
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon TreatmentChronic Hepatitis BNCT02336399Beijing Ditan Hospital420
已完成
不适用
HBsAg clearance with pegylated interferon and tenofovir combinatioISRCTN12811193King Faisal Specialist Hospital and Research Centre50
Unknown
不适用
Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaLiver CirrhosisChronic HepatitisNCT03892681Yonsei University129